319 related articles for article (PubMed ID: 15572648)
1. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C
J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury.
Patel NS; Cortes U; Di Poala R; Mazzon E; Mota-Filipe H; Cuzzocrea S; Wang ZQ; Thiemermann C
J Am Soc Nephrol; 2005 Mar; 16(3):712-9. PubMed ID: 15677308
[TBL] [Abstract][Full Text] [Related]
4. IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury.
Burne MJ; Elghandour A; Haq M; Saba SR; Norman J; Condon T; Bennett F; Rabb H
J Leukoc Biol; 2001 Aug; 70(2):192-8. PubMed ID: 11493610
[TBL] [Abstract][Full Text] [Related]
5. The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-αR1: a comparison with infliximab treatment.
Di Paola R; Genovese T; Impellizzeri D; Ahmad A; Cuzzocrea S; Esposito E
Eur J Pharmacol; 2013 Jan; 700(1-3):134-46. PubMed ID: 23291313
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury.
Patel NS; di Paola R; Mazzon E; Britti D; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2009 Feb; 328(2):635-43. PubMed ID: 18997058
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Di Paola R; Impellizzeri D; Mondello P; Velardi E; Aloisi C; Cappellani A; Esposito E; Cuzzocrea S
Shock; 2012 Oct; 38(4):356-66. PubMed ID: 22772472
[TBL] [Abstract][Full Text] [Related]
8. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat.
Sivarajah A; Chatterjee PK; Hattori Y; Brown PA; Stewart KN; Todorovic Z; Mota-Filipe H; Thiemermann C
Med Sci Monit; 2002 Dec; 8(12):BR532-9. PubMed ID: 12503032
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice.
Yang GY; Schielke GP; Gong C; Mao Y; Ge HL; Liu XH; Betz AL
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1109-17. PubMed ID: 10532635
[TBL] [Abstract][Full Text] [Related]
10. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
Chatterjee PK; Patel NS; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Eberhardt W; Pfeilschifter J; Thiemermann C
Cardiovasc Res; 2004 Feb; 61(3):630-43. PubMed ID: 14962493
[TBL] [Abstract][Full Text] [Related]
11. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Di Paola R; Genovese T; De Sarro A; Caputi AP
Eur Cytokine Netw; 2002; 13(3):285-97. PubMed ID: 12231472
[TBL] [Abstract][Full Text] [Related]
12. Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury.
Rusai K; Huang H; Sayed N; Strobl M; Roos M; Schmaderer C; Heemann U; Lutz J
Transpl Int; 2008 Jun; 21(6):572-80. PubMed ID: 18363573
[TBL] [Abstract][Full Text] [Related]
13. Role of endogenous interleukin-10 in local and distant organ injury after visceral ischemia-reperfusion.
Welborn MB; Moldawer LL; Seeger JM; Minter RM; Huber TS
Shock; 2003 Jul; 20(1):35-40. PubMed ID: 12813366
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury.
Burne-Taney MJ; Kofler J; Yokota N; Weisfeldt M; Traystman RJ; Rabb H
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F87-94. PubMed ID: 12657560
[TBL] [Abstract][Full Text] [Related]
15. Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse.
Welborn MB; Douglas WG; Abouhamze Z; Auffenburg T; Abouhamze AS; Baumhofer J; Seeger JM; Pruitt JH; Edwards PD; Chizzonite R; Martin D; Moldawer LL; Harward TR
Shock; 1996 Sep; 6(3):171-6. PubMed ID: 8885081
[TBL] [Abstract][Full Text] [Related]
16. Effects of trapidil on renal ischemia-reperfusion injury.
Avlan D; Tamer L; Ayaz L; Polat A; Oztürk C; Ozturhan H; Camdeviren H; Aksöyek S
J Pediatr Surg; 2006 Oct; 41(10):1686-93. PubMed ID: 17011270
[TBL] [Abstract][Full Text] [Related]
17. Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation.
Jiang SH; Liu CF; Zhang XL; Xu XH; Zou JZ; Fang Y; Ding XQ
Cell Biochem Funct; 2007; 25(3):335-43. PubMed ID: 17221834
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion.
Kaczorowski DJ; Nakao A; Mollen KP; Vallabhaneni R; Sugimoto R; Kohmoto J; Tobita K; Zuckerbraun BS; McCurry KR; Murase N; Billiar TR
Transplantation; 2007 Nov; 84(10):1279-87. PubMed ID: 18049113
[TBL] [Abstract][Full Text] [Related]
19. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha.
Esposito E; Mazzon E; Muià C; Meli R; Sessa E; Cuzzocrea S
J Leukoc Biol; 2007 Apr; 81(4):1032-43. PubMed ID: 17210619
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
